The age-standardized MIR had a favorable trend over time for both sexes (from 34.3 to 22.8), and for both males (from 35.2 to 24.1) and females (from 34.5 to 21.8).
← all excerpts
The national and subnational burden of Non-Hodgkin Lymphomas (NHL) in Italy from 1990 to 2023: results from the Global Burden of Disease Study 2023.
1
—
—